Babe star reveals stage four cancer diagnosis
The 64-year-old resident of Melbourne, Australia shared on social media that she has begun treatment for stage four mantle cell lymphoma.
It is a "rare and fast-moving blood cancer", she said.
However, Szubanski conveyed a message of hope, saying: "It's serious, but I've started one of the best treatments available (the Nordic protocol), and I'm lucky to be getting absolutely world-class care here in Melbourne."
She added: "I won't sugar-coat it: it's rough. But I'm hopeful.
'I'm being lovingly cared for by friends and family, my medical team is brilliant, and I've never felt more held by the people around me.'
Szubanski said that she had shaved her head before appearing in a video 'in anticipation of it all falling out in a couple of weeks'. That was an apparent reference to undergoing chemotherapy.
Mantle cell lymphoma is a rare type of non-Hodgkin lymphoma, according to Cancer Research UK.
It makes up just 5 per cent of all non-Hodgkin lymphoma cases. About 600 people in the UK are diagnosed with mantle cell lymphoma each year.
Szubanski received international acclaim for her role as the farmer's wife Esme Hoggett in the 1995 movie Babe.
The film, which is based on a book by Dick King-Smith and tells the tale of a pig that wants the job of a sheepdog, was nominated for seven Academy Awards.
Szubanski reprised the role in the 1998 sequel, Babe: Pig in the City.
She also played sports-loving Sharon Strzelecki in the Australian sitcom Kath and Kim. The series ran from 2002 to 2005 and inspired an American remake with the same name.
Szubanski voiced the role of Miss Viola in the animated films Happy Feet in 2006 and Happy Feet Two in 2011. Both films, about a penguin that loves to dance, were produced and directed by George Miller.
Szubanski was born in Liverpool, England, on April 12, 1961, and moved to Melbourne with her family in 1966.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
Cantargia Publishes Half-Year Report 2025
LUND, SE / / August 21, 2025 / Cantargia AB (publ) [Nasdaq Stockholm:CANTA] (Cantargia) today issued the interim report for January to June 2025. "I started my tenure as interim CEO with a strong focus on looking to deliver at least one transformative transaction during 2025. I am delighted for all Cantargia's stakeholders, including our loyal shareholders, our employees and patients in need, that we have been able to deliver on this goal with the Otsuka agreement. Not only does the deal bring significant non-dilutive financial resources but, equally importantly, it provides clear validation of Cantargia's technology and platform. Cantargia is now on a solid footing and our next important task is to prioritize those programs and activities on which we will focus our resources going forward." said Damian Marron, Interim CEO of Cantargia. Significant events in the second quarter Cantargia appointed Morten Lind Jensen as Chief Medical Officer. Treatment resistant atopic dermatitis (AD) was selected as second indication for CAN10's phase 2 program. Pharmacokinetic modelling confirmed the choice of Q4W dosing in phase 2 for CAN10. US FDA awarded nadunolimab Fast Track Designation. Cantargia signed a loan facility of SEK 50 million. Significant events after the end of the period Otsuka Pharmaceuticals acquired CAN10 for an upfront of MUSD 33 plus an additional MUSD 580 in potential milestone payments and up to double digit earn-outs on future sales. The deal is expected to close in Q3 2025. Preliminary results from the TRIFOUR phase 2 study in TNBC did not demonstrate a difference in overall response rate (ORR) between nadunolimab in combination with chemotherapy vs. chemotherapy alone. Cantargia appointed Dr Hilde H. Steineger as new CEO effective from September 1, 2025. Financial information Second quarter 2025 (April 1 - June 30) Net sales: SEK 0.0 M (0.0) Operating loss: SEK -39.5 M (-43.8) Loss after tax: SEK -39.3 M (-43.3) Loss per share, before and after dilution: SEK -0.16 (-0.24) First six months of 2025 (January 1 - June 30) Net sales: SEK 0.0 M (0.0) Operating loss: SEK -84.5 M (-85.5) Loss after tax: SEK -86.2 M (-80.2) Loss per share: before and after dilution, SEK -0.35 (-0.44) Equity/assets ratio: 34 (74) per cent Cash and cash equivalents: SEK 81.9 M (84.7) Short-term investments: SEK 0.0 M (20.0) In conjunction to the report, Cantargia invites investors, analysts, and media to an audiocast with teleconference on August 21, at 3:00 p.m. CEST, where Cantargia's interim CEO Damian Marron, CBO Ton Berkien, and CFO Patrik Renblad, will present Cantargia and comment on the report, followed by a Q&A-session. If you wish to participate via audiocast, please use the link below. Via the web session you will be able to ask written questions. Webcast: . If you wish to participate via teleconference, please register on the link below. After registration you will be provided with phone numbers and a conference ID to access the conference. You can ask questions verbally via the .The webcast will also be available on demand on Cantargia's corporate website: For further information, please contactDamian Marron, Interim CEOTelephone: +46 (0)46-275 62 60E-mail: This information is information that Cantargia is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-08-21 07:00 CEST. About CantargiaCantargia AB (publ), reg. no. 556791-6019, is a biotechnology company that develops antibody-based treatments for life-threatening diseases and has established a platform based on the protein IL1RAP, involved in a number of cancer forms and inflammatory diseases. Cantargia's oncology program, the antibody nadunolimab (CAN04), is being studied clinically, primarily in combination with chemotherapy with a focus on pancreatic cancer, non-small cell lung cancer and triple-negative breast cancer. Positive data for the combinations indicate stronger efficacy than would be expected from chemotherapy alone. Cantargia's second development program, the antibody CAN10, blocks signaling via IL1RAP in a different manner than nadunolimab and addresses treatment of serious autoimmune/inflammatory diseases. Cantargia has entered an agreement with Otsuka Pharmaceuticals on the acquisition of the CAN10 program. Cantargia is listed on Nasdaq Stockholm (ticker: CANTA). More information about Cantargia is available at . AttachmentsInterim Report January June 2025 SOURCE: Cantargia View the original press release on ACCESS Newswire Sign in to access your portfolio
Yahoo
18 hours ago
- Yahoo
'Star Trek: Strange New Worlds' Goes Full Documentary in This Week's Episode
'Star Trek: Strange New Worlds' Goes Full Documentary in This Week's Episode originally appeared on Parade. In the latest episode of Star Trek: Strange New Worlds, the crew of the Enterprise is actually exploring a strange new world! Beto's (Mynor Luken) documentary on Starfleet takes shape while the Enterprise is on a mission assisting a non-Federation alien race. But their mission puts them in the path of another species, which puts them in a moral quandary. If they help one, they may harm another. What should they do? Read on for more about the episode "What is Starfleet?" 🎬 SIGN UP for Parade's Daily newsletter to get the latest pop culture news & celebrity interviews delivered right to your inbox 🎬 What happened in last week's episode of Star Trek: Strange New Worlds? In "The Sehlat Who Ate Its Tail," it was Lieutenant Commander James Kirk's (Paul Wesley) first day in the Captain's chair of the U.S.S. Farragut. In the beginning, he was a bit bored with the monotony of the daily routine. But it wasn't all smooth sailing when the day took a disastrous turn after the Enterprise was captured by a deadly Scavenger Ship. But the alien menace was not exactly what it seemed… Related: What happens in this week's episode of Star Trek: Strange New Worlds? In this week's episode, "What is Starfleet?," we are privy to an inside look at the documentary produced by Beto Ortegas, Erica's (Melissa Navia) baby brother. The film follows the crew of the Enterprise as they go on a mission to assist a non-Federation race, but in helping one race they may inadvertently harm another. The crew then faces a moral dilemma as tensions arise with a difference of opinions. Whatever choice is made may alter the course of both civilizations. Check out images from this week's episode of Star Trek: Strange New Worlds Take a look at select images from this week's episode of Star Trek: Strange New Worlds. Star Trek: Strange New Worlds Season 3 Episode 7 Paramount+'Star Trek: Strange New Worlds' Goes Full Documentary in This Week's Episode first appeared on Parade on Aug 19, 2025 This story was originally reported by Parade on Aug 19, 2025, where it first appeared. Solve the daily Crossword
Buzz Feed
20 hours ago
- Buzz Feed
23 Bizarre Facts That Sound Fake But Are Actually True
Until 2015 in the UK, the coloring in red skittles contained carmine, which derives from the crushed abdomen of female beetles. There's an 80% chance your toothbrush has fecal matter on it. Even if it's stored in a closed container. Even toothbrushes stored outside the bathroom may be contaminated with fecal matter. Winnie the Pooh was banned from a Polish playground because he doesn't wear pants. The casting team for the Harry Potter movies was strongly against non-British actors being a part of the film, which meant that Robin Williams was turned down for Hagrid. Liam Aiken was the only American actor who even got the chance to audition for Harry Potter. Aside from that one exception, the casting team insisted on hiring only British actors. Because of that rule, Robin Williams reached out to director Chris Columbus about playing Hagrid but was politely turned down. As casting director Janet Hirshenson later explained, once Columbus said no to Robin, there was no way he was going to make an exception for anyone else. Cows have accents, and it goes way beyond moo! UK dairy farmers observed that cows seemed to moo with slight variations depending on the region. Curious about this, researchers from the University of London conducted a study and confirmed it — cows really do have regional differences in their moos. Interestingly, birds are also known to develop distinct local dialects. Nutmeg isn't just used in food. It can also be hallucinogenic if consumed in large doses. McDonald's used to have stirring spoons for their coffee until people began using them to snort cocaine. Pirates wore eye patches not because they were missing an eye, but to keep one eye adjusted to darkness. This let them switch quickly between bright sunlight above deck and the dim conditions below deck, giving them an advantage in battle or while moving through the ship. You can actually go to Norway that is, or even Hell, Michigan. And don't worry, it doesn't really get hot. Pope John Paul II is an honorary Harlem Globetrotter. Believe it or not, the largest tire manufacturer in the world In 2011, Guinness World Records named Lego the biggest tire manufacturer in the world. That year, the company produced 381 million tiny tires — far more than Bridgestone's 190 million, Michelin's 184 million, or Goodyear's 181 million. Sure, Lego tires are much easier to make since they're miniature and don't require everything an actual motor vehicle tire needs, but the numbers are still surprising! Roses are among the oldest plants on Earth, with fossils dating back 35 million years. The oldest living rose, which grows on a wall at Hildesheim Cathedral in Germany, is over 1,000 years old — and amazingly, it even survived a World War II bombing. President Theodore Roosevelt had a pet hyena named Bill. There's a pretty high chance that the ground coffee you use likely contains cockroaches. On August 9, 1996, production on Titanic took an unexpected and alarming turn when almost 80 cast and crew members were sent to the hospital after eating clam chowder on set. At first, the incident was thought to be a case of food poisoning, but a Nova Scotia newspaper later reported that the chowder had been deliberately spiked with PCP. Among those affected were actor Bill Paxton and director James Cameron. It's wild to think about, but none of us have ever actually seen our own faces — only reflections and images. Every time we look in a mirror or scroll past a photo, we're only catching a filtered representation. The world sees us directly, but we only know ourselves through glass and pixels. Stop signs used to be yellow. Before the 1920s, stop signs didn't follow any uniform rules — they came in all different shapes and colors. In 1922, the American Association of State Highway Officials decided that stop signs should be yellow and octagon-shaped. At the time, they didn't choose red because red paint tended to fade quickly and appeared too dark at night. It wasn't until the 1950s, after more durable red paint was developed, that the now-familiar red stop sign became the standard. There's actually a gender-neutral word for "niece" or "nephew" — It's "nibling." If you're brother or sister is becoming a parent but they don't know the sex yet, you could easily say, "I have a nibling on the way!" "Paul Winchell, who voiced Tigger in The Many Adventures of Winnie the Pooh, invented an artificial heart." Technically, strawberries and raspberries aren't berries, but bananas and avocados are. Strawberries aren't considered true berries because they don't develop from a single ovary — instead, each tiny seed on the outside comes from its own ovary. Bananas, on the other hand, grow from a single ovary and meet the botanical definition of a berry, which is why they count as one. Before people became obsessed with painting fake freckles on their faces, people wore fake moles made of things like silk, velvet, and even mouse skin as a fashion statement. While stars like Marilyn Monroe, Eva Mendes, and Cindy Crawford popularized beauty marks, people wore facial patches for a variety of reasons. Some covered scars or blemishes, others made political statements, and some even used them to express their personality or relationship status. These patches came in all sorts of shapes — circles, hearts, stars, and moons. The trend saw a short revival in the 1940s before disappearing again. The dot over the lowercase letters 'i' and 'j' actually has a name. It's called a tittle. It appears to be a blend of the words "tiny" and "little"...now how adorable is that?! Lastly, Rapper Pusha T and Justin Timberlake wrote the "I'm Lovin' It" jingle for McDonald's. Unfortunately, they were only paid a one-time fee, and they don't own any publishing rights. Pusha T mentioned in a podcast that he received a $500,000 upfront payment for a jingle — a hefty sum, but he doesn't hold any publishing rights to it. Since the jingle has been used for years, he likely could have made much more if he had. On the other hand, he also created the jingle for Arby's 'We Have the Meats' slogan, and he owns 40% of the publishing rights for that one. Do you have a cool fact to share? Let me know in the comments!
